Featured
Genetically Modified
Sugar Editorial Picks
Beer: The Next Cancer Elixir?
While we recently learned that Americans are drinking less beer, perhaps they should reconsider.
Recent studies show that xanthohumol, a chemical found in hops, can inhibit enzymes that trigger cancer as well as help detoxify the body of carcinogens.
In addition, other researchers at Rice University are trying to genetically engineer brewing yeast in order to create beer loaded with resveratrol, a cancer-preventing compound.
Would You Buy Genetically Modified Food?
A recent CBS News/New York Times poll shows that 53 percent of Americans won't buy food that has been genetically modified. I can see where folks would be concerned, and wondered what you thought? Would you purchase food that had been genetically modified?
Other Search Results
What Does "No GMO" Really Mean?
I've seen "No GMO" written on many food products lately, so what does that word combination really mean?
Well, first off, GMO stands for "genetically modified organism." It can be a plant, animal, or microorganism that is genetically changed.
Rheumatoid arthritis
In This Report- Highlights
- Introduction
- Causes
- Risk Factors
- Symptoms
- Complications
- Diagnosis
- Treatment
- Medications
- Surgery
- Lifestyle Changes
- Resources
- References
- Patients with rheumatoid arthritis who do not respond to single-drug therapy often do better when a combination of drugs is used, indicates a review of 23 clinical trials published in 2007 in the Annals of Internal Medicine. However, the researchers were unable to determine which combinations of drugs work best or which individual drugs are more effective than others.
- Combination drug treatment is now becoming a standard approach to treating rheumatoid arthritis while it is still in its early stages. Another 2007 Annals of Internal Medicine study indicated that initial combination therapies slow progression of joint damage more rapidly than single-drug therapy but, after several years, all treatment strategies produce benefits.
Crohn's disease
In This Report- Highlights
- Introduction
- Causes
- Symptoms
- Complications
- Risk Factors
- Diagnosis
- Dietary Factors
- Symptom Management
- Medications
- Surgery
- Resources
- References
- In February 2007, the FDA approved adalimumab (Humira) for treatment of adult patients with moderate-to-severe Crohn’s disease. Adalimumab and infliximab (Remicade) are now the two biologic drugs approved for Crohn’s disease. Infliximab is approved for treating both adults and children.
- As of August 2007, the FDA was considering approving natalizumab (Tysabri) for moderate-to-severe Crohn’s disease in patients who have not responded to, or cannot tolerate, other therapies.
Multiple sclerosis
In This Report- Highlights
- Introduction
- The Autoimmune Disease Proc...
- Symptoms
- Causes
- Risk Factors
- Complications
- Diagnosis
- Treatment
- Drug Treatment
- Other Treatments
- Treating the Complications...
- Lifestyle Changes
- Resources
- References
Breast cancer
In This Report- Highlights
- Introduction
- Risk Factors
- Prevention and Lifestyle Fa...
- Symptoms
- Diagnosis
- Prognosis
- Treatment
- Surgery
- Radiation
- Medications
- Chemotherapy
- Hormone Therapy
- Resources
- References
- In September 2007, Evista (raloxifene) was approved for prevention of breast cancer in postmenopausal women with osteoporosis, and postmenopausal women at high risk for invasive breast cancer. Raloxifene and tamoxifen are the only two drugs approved for breast cancer prevention in high-risk women.
- In March 2007, lapatinib (Tykerb) was approved in combination with capecitabine (Xeloda) for treatment of advanced HER2-positive breast cancer.
- In November 2006, trastuzumab (Herceptin) was approved for treatment of early-stage HER2-positive breast cancer. Trastuzumab is also approved for advanced HER2-positive breast cancer.
- The American College of Physicians’ 2007 guidelines recommend that women with a low risk for breast cancer talk to their doctor before starting to have mammogram screening at age 40.
Infertility in women
In This Report- Highlights
- Introduction
- The Reproductive System
- Risk Factors
- Causes
- Diagnosis
- Treatment
- Lifestyle Changes
- Medications
- Assisted Reproductive Techn...
- Complications of Assisted R...
- Resources
- References
Scleroderma
In This Report- Highlights
- Introduction
- Symptoms and Complications...
- Causes
- Risk Factors
- Prognosis
- Diagnosis
- Treatment
- Medications
- Other Treatments
- Treatment for Raynaud's Phe...
- Treatment for Skin Thickeni...
- Treatment for Lung Complica...
- Treatment for Gastrointesti...
- Resources
- References
- Because significant depression can affect more than 50% of people with scleroderma, researchers say it may be beneficial for scleroderma patients to get routine screening for depression.
- Researchers have discovered a gene called connective-tissue growth factor (CTGF), which they say is more common in people with systemic scleroderma than in those without the disease.
- The prognosis for patients with systemic scleroderma has improved since the 1970s. Ten-year survival rates are up, and deaths from kidney crises have dropped. However, deaths from pulmonary fibrosis have increased during this time period.
- High-dose immunosuppressant therapy with cyclophosphamide significantly improved skin and overall function in patients with scleroderma.
- Evidence shows that intravenous iloprost given in progressively increasing doses can reduce the duration and frequency of Raynaud's phenomenon attacks.
- A potential new therapy using PVAC, a substance derived from the bacterium, Mycobacterium vaccae, can improve skin symptoms without causing significant side effects.
Melanoma and other skin cancers
In This Report- Highlights
- Introduction
- Melanoma
- Nonmelanoma Skin Cancer
- Precancerous Skin Condition...
- Causes
- Risk Factors
- Prevention
- Screening
- Diagnosis
- Staging
- Treatment for Melanoma
- Treatment for Nonmelanoma S...
- Prognosis
- Resources
- References
More on YumSugar
Top Brands
Lee
Miu Miu
Halston